Sarepta Therapeutics Market Sentiment

Sarepta Therapeutics Inc

SRPTNASDAQ

Trade with Public

$17.50

-0.07-0.4%

Ult. Agg.: Oct 2, 4:32 PM

$17.50

-0.07-0.4%

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

Sarepta Therapeutics Market Sentiment - Benzinga

Sarepta Therapeutics Market Sentiment

Market sentiment signals for Sarepta Therapeutics (SRPT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Outperform

Short Interest▼ 28.9% short float

Options Flow▲ 0.45 P/C ratio

Insider Activity— N/A

Analyst Consensus

Outperform

29 analysts

Options Flow (P/C)

0.45

More calls — Bullish

530 calls · 236 puts

Avg Consensus PT

$25

+41.4%

Highest Price Target

$80

+357.1%

Scotiabank

Lowest Price Target

-71.4%

HC Wainwright & Co.

Short Interest

28.9%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 30, 2026	JP Morgan	Anupam Rama—	+14.3%	$23 → $20	Maintained	Neutral
Sep 28, 2026	Needham	Gil Blum—	—	—	Maintained	Underperform
Jul 9, 2026	Piper Sandler	Biren Amin—	+14.3%	$23 → $20	Maintained	Neutral
Jul 9, 2026	Wolfe Research	Andy Chen—	+54.3%	$27	Upgrade	Peer Perform→Outperform
Apr 16, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-71.4%	$5 → $5	Maintained	Sell
Mar 26, 2026	Citigroup	Yigal Nochomovitz—	-25.7%	$9 → $13	Maintained	Sell
Mar 26, 2026	Needham	Gil Blum—	—	—	Maintained	Underperform
Mar 19, 2026	Oppenheimer	Kostas Biliouris—	+111.4%	$37 → $37	Maintained	Outperform
Mar 13, 2026	Mizuho	Uy Ear—	+77.1%	$26 → $31	Maintained	Outperform
Mar 10, 2026	Citigroup	Yigal Nochomovitz—	-48.6%	$8 → $9	Maintained	Sell
Mar 2, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-71.4%	$5 → $5	Maintained	Sell
Feb 27, 2026	Wells Fargo	Yanan Zhu—	+117.1%	$45 → $38	Maintained	Overweight
Jan 27, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-71.4%	$5 → $5	Maintained	Sell
Jan 23, 2026	Wedbush	Yun Zhong—	+94.3%	$32 → $34	Maintained	Outperform
Jan 14, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	-71.4%	$5 → $5	Maintained	Sell
Dec 9, 2025	Wedbush	Yun Zhong—	+82.9%	$32	Initiate	Outperform
Nov 5, 2025	Barclays	Gena Wang—	+14.3%	$22 → $20	Maintained	Equal-Weight
Nov 5, 2025	Wells Fargo	Yanan Zhu—	+157.1%	$50 → $45	Maintained	Overweight
Nov 5, 2025	Guggenheim	Debjit Chattopadhyay—	+8.6%	$22 → $19	Maintained	Buy
Nov 5, 2025	Mizuho	Uy Ear—	+48.6%	$19 → $26	Upgrade	Neutral→Outperform
Nov 4, 2025	Baird	Brian Skorney—	-14.3%	$21 → $15	Maintained	Neutral
Oct 30, 2025	Piper Sandler	Biren Amin—	-8.6%	$15 → $16	Maintained	Neutral
Sep 22, 2025	BMO Capital	Kostas Biliouris—	+185.7%	$50 → $50	Upgrade	Market Perform→Outperform
Sep 15, 2025	Guggenheim	Debjit Chattopadhyay—	+25.7%	$22 → $22	Maintained	Buy
Sep 9, 2025	Leerink Partners	Joseph Schwartz—	-14.3%	$12 → $15	Maintained	Market Perform